POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION Monday, March 9, 2009   —  9:30 AM - 12:00 Noon Hynes Convention Center, Hall C/D Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... ENDOCRINE PATHOLOGY Poster# Title and Authors Itinerary Planner 85 Palladin Is a Novel Marker of Metastasis in Primary Pancreatic Endocrine Neoplasms (519) EB Henderson-Jackson, L Turner, N Hafez, NA Nasir, J Strosberg, J Helm, D Agrawal, MM Bui, D Coppola, SV Nicosia, L Kvols, MP Malafa, A Nasir - H Lee Moffitt Cancer Center and Research Institute, Tampa, FL; University of South Florida College of Medicine, Tampa, FL Add 86 MicroRNA Analysis in Common Thyroid Neoplasms as an Aid for Diagnostic Evaluation (522) Y Li, GA Barkan, S Alkan - Loyola University Medical Center, Maywood, IL Add 87 Cribriform-Morular Variant of Thyroid Carcinoma: Distinct Immunohistochemical Profile from Other Papillary Thyroid Carcinoma Variants (523) SB Lovitch, W Faquin, V Nose - Brigham and Women's Hospital and Massachusetts General Hospital, Boston, MA Add 88 Thrombospondin-1 Is Modulated by the B-RafV600E Pathway in Papillary Thyroid Cancer (528) C Nucera, A Porrello, Z Antonello, S Finn, C Priolo, T Giordano, B Jarzab, F Trimarchi, A Pontecorvi, V Nose, J Lawler, S Parangi - Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Brigham & Women's Hospital, Harvard Medical School, Boston, MA; Duke Univ, Durham, NC; DFCI; Michigan Univ, MI; Gliwice Univ, Gliwice, Poland; Messina Univ, Messina, Italy; Catholic Univ, Rome, Italy Add 89 A Paucity of Colonic Endocrine Cells Characterizes a Subset of Patients with Malabsorption and/or Diarrhea (529) SJ Ohsie, G Gerney, D Gui, D Kahana, MG Martin, G Cortina - UCLA, Los Angeles, CA Add 90 Evaluating the Specificity of CD56 as a Neuroendocrine Immunohistochemical Marker (535) SM Share, MA Laws, NT Sherwood, JF Silverman, K Ru - Allegheny General Hospital, Pittsburgh, PA Add 91 Stem Cell Marker Kit Is an Independent Prognostic Marker for Pancreatic Endocrine Tumors - A Novel Finding Derived from Analysis of Islet Cell Differentiation Markers (540) L Zhang, TC Smyrk, C Lohse, RV Lloyd - Mayo Clinic, Rochester, MN Add